Contravisory Investment Management, Inc. United Therapeutics Corp Transaction History
Contravisory Investment Management, Inc.
- $453 Million
- Q3 2024
A detailed history of Contravisory Investment Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 55 shares of UTHR stock, worth $21,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55Holding current value
$21,244% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
657Shares Held
42.8MCall Options Held
153KPut Options Held
278K-
Black Rock Inc. New York, NY5.47MShares$2.11 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.7 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.22 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.1 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$865 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $17.6B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...